Deal Announcements

Cardioxyl Pharma Nets $15 Million In VC Funding

Tuesday, August 03, 2010 5:51:00 AM PDT | VentureDeal Staff

Chapel Hill, North Carolina  --  Cardioxyl Pharmaceuticals has secured $15 million in its latest venture capital financing round.

Cardioxyl is developing new classes of therapeutic agents for the treatment of acute decompensated heart failure.

Investors in the round were Aurora Funds and New Enterprise Associates. The company is going to continue trials for its lead candidate CXL-1020.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1